Marshman Fund Trust II is 10% Owner at Harmony Biosciences Holdings, Inc. (HRMY). They have made 1 open-market trade across 1 company since 2020, most recently 2020-08-21.
CIK 0001821461
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8.1M since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HRMY | 6,651,120 | $252.3M |
Shares reported on the most recent Form 4, priced at the 2024-11-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HRMY | BUY | 2020-08-21 | 2020-10-16 | $24.00 | $8.1M | -1.0% | +7.3% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.